ArticleThe Journal of innovations in cardiac rhythm management2026
Advanced Electroanatomic Mapping with the TriDeca™ Catheter in Left Ventricular Assist Device-associated Ventricular Tachycardia: A Report of Two Cases.
Article in The Journal of innovations in cardiac rhythm management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Letter from the Editor in Chief.The Journal of innovations in cardiac rhythm management · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ventricular tachycardia (VT) in patients with left ventricular assist devices (LVADs) poses significant procedural challenges for catheter ablation due to altered cardiac anatomy, mechanical interference, and hemodynamic instability. High-density (HD) mapping technologies may improve procedural efficacy and safety in this complex population. We present two cases of drug-refractory monomorphic VT in patients supported by HeartMate 3™ LVADs (Abbott, Chicago, IL, USA), successfully managed using the TriDeca™ HD linear mapping catheter (Stereotaxis, St. Louis, MO, USA). In both cases, precise localization of slow conduction zones and targeted substrate ablation resulted in sustained arrhythmia suppression without recurrence during follow-up. These cases highlight the value of advanced mapping systems in overcoming LVAD-related limitations and optimizing ablation outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.